|
1
|
Drevon CA: Marine oils and their effects.
Nutr Rev. 50:38–45. 1992. View Article : Google Scholar
|
|
2
|
Song C and Zhao S: Omega-3 fatty acid
eicosapentaenoic acid. A new treatment for psychiatric and
neurodegenerative diseases: a review of clinical investigations.
Expert Opin Investig Drugs. 16:1627–1638. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yokoyama M and Origasa H; JELIS
Investigators. Effects of eicosapentaenoic acid on cardiovascular
events in Japanese patients with hypercholesterolemia: rationale,
design, and baseline characteristics of the Japan EPA Lipid
Intervention Study (JELIS). Am Heart J. 146:613–620. 2003.
View Article : Google Scholar
|
|
4
|
Miyajima T, Tsujino T, Saito K and
Yokoyama M: Effects of eicosapentaenoic acid on blood pressure,
cell membrane fatty acids, and intracellular sodium concentration
in essential hypertension. Hypertens Res. 24:537–542. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peet M, Brind J, Ramchand CN, Shah S and
Vankar GK: Two double-blind placebo-controlled pilot studies of
eicosapentaenoic acid in the treatment of schizophrenia. Schizophr
Res. 49:243–251. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calder PC: Session 3: Joint Nutrition
Society and Irish Nutrition and Dietetic Institute Symposium on
‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and
rheumatoid arthritis. Proc Nutr Soc. 67:409–418. 2008.
|
|
7
|
Singh M: Essential fatty acids, DHA and
human brain. Indian J Pediatr. 72:239–242. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pifferi F, Perret M, Guesnet P, Aujard F
and Alessandri JM: Fatty acid composition of the brain, retina,
liver and adipose tissue of the grey mouse lemur (Microcebus
murinus, primate). Lipids. 47:793–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cunnane SC, Plourde M, Pifferi F, Bégin M,
Féart C and Barberger-Gateau P: Fish, docosahexaenoic acid and
Alzheimer’s disease. Prog Lipid Res. 48:239–256. 2009.
|
|
10
|
Fotuhi M, Mohassel P and Yaffe K: Fish
consumption, long-chain omega-3 fatty acids and risk of cognitive
decline or Alzheimer disease: a complex association. Nat Clin Pract
Neurol. 5:140–152. 2009. View Article : Google Scholar
|
|
11
|
McNamara RK, Hahn CG, Jandacek R, Rider T,
Tso P, Stanford KE and Richtand NM: Selective deficits in the
omega-3 fatty acid docosahexaenoic acid in the postmortem
orbitofrontal cortex of patients with major depressive disorder.
Biol Psychiatry. 62:17–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SP, LaMont JT and Carey MC: Role of
gallbladder mucus hypersecretion in the evolution of cholesterol
gallstones. J Clin Invest. 67:1712–1723. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang DQ, Paigen B and Carey MC: Phenotypic
characterization of Lith genes that determine susceptibility to
cholesterol cholelithiasis in inbred mice: physical-chemistry of
gallbladder bile. J Lipid Res. 38:1395–1411. 1997.
|
|
14
|
Vilkin A, Nudelman I, Morgenstern S,
Geller A, Bar Dayan Y, Levi Z, Rodionov G, Hardy B, Konikoff F,
Gobbic D and Niv Y: Gallbladder inflammation is associated with
increase in mucin expression and pigmented stone formation. Dig Dis
Sci. 52:1613–1620. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chuang SC, Hsi E and Lee KT: Mucin genes
in gallstone disease. Clin Chim Acta. 413:1466–1471. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KT and Liu TS: Mucin gene expression
in gallbladder epithelium. J Formos Med Assoc. 101:762–768.
2002.PubMed/NCBI
|
|
17
|
Fischer S, Müller I, Zündt BZ, Jüngst C,
Meyer G and Jüngst D: Ursodeoxycholic acid decreases viscosity and
sedimentable fractions of gallbladder bile in patients with
cholesterol gallstones. Eur J Gastroenterol Hepatol. 16:305–311.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Venneman NG, Besselink MG, Keulemans YC,
Vanberge-Henegouwen GP, Boermeester MA, Broeders IA, Go PM and van
Erpecum KJ: Ursodeoxycholic acid exerts no beneficial effect in
patients with symptomatic gallstones awaiting cholecystectomy.
Hepatology. 43:1276–1283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lioudaki E, Ganotakis ES and Mikhailidis
DP: Lipid lowering drugs and gallstones: a therapeutic option? Curr
Pharm Des. 17:3622–3631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JK, Cho SM, Kang SH, Kim E, Yi H, Yun
ES, Lee DG, Cho HJ, Paik YH, Choi YK, Haam SJ, Shin HC and Lee DK:
N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by
suppressing mucin production with a high cholesterol diet in mice.
J Gastroenterol Hepatol. 27:1745–1751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krauss RM, Eckel RH, Howard B, Appel LJ,
Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg
IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K,
Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL and Bazzarre TL:
AHA Dietary Guidelines: revision 2000: A statement for healthcare
professionals from the Nutrition Committee of the American Heart
Association. Circulation. 102:2284–2299. 2000. View Article : Google Scholar
|
|
22
|
Kris-Etherton PM, Harris WS and Appel LJ;
American Heart Association. Nutrition Committee. Fish consumption,
fish oil, omega-3 fatty acids, and cardiovascular disease.
Circulation. 106:2747–2757. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Magnuson TH, Lillemoe KD, High RC and Pitt
HA: Dietary fish oil inhibits cholesterol monohydrate crystal
nucleation and gallstone formation in the prairie dog. Surgery.
118:517–523. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scobey MW, Johnson FL, Parks JS and Rudel
LL: Dietary fish oil effects on biliary lipid secretion and
cholesterol gallstone formation in the African green monkey.
Hepatology. 14:679–684. 1991.PubMed/NCBI
|
|
25
|
Mizuguchi K, Yano T, Kawano H, Abei M and
Tanaka N: Preventive effects of eicosapentaenoic acid (EPA) on
cholesterol gallstone formation in hamsters. Nihon Yakurigaku
Zasshi. 110(Suppl 1): 50P–55P. 1997.(In Japanese).
|
|
26
|
Womack NA: The development of gallstones.
Surg Gynecol Obstet. 133:937–945. 1971.
|
|
27
|
Janowitz P, Swobodnik W, Wechsler JG,
Janowitz A, Saal D and Ditschuneit H: Fish oil, enriched with
polyunsaturated fatty acids of the omega-3-type accelerates the
nucleation time in healthy subjects. Klin Wochenschr. 69:289–293.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Weber LW, Boll M and Stampfl A:
Maintaining cholesterol homeostasis: sterol regulatory
element-binding proteins. World J Gastroenterol. 10:3081–3087.
2004.PubMed/NCBI
|
|
29
|
Trapani L, Segatto M, Simeoni V, Balducci
V, Dhawan A, Parmar VS, Prasad AK, Saso L, Incerpi S and Pallottini
V: Short- and long-term regulation of 3-hydroxy 3-methylglutaryl
coenzyme A reductase by a 4-methylcoumarin. Biochimie.
93:1165–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
